GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (MEX:BHC) » Definitions » Shiller PE Ratio

Bausch Health (MEX:BHC) Shiller PE Ratio : (As of May. 01, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Bausch Health Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Shiller PE Ratio Historical Data

The historical data trend for Bausch Health's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Shiller PE Ratio Chart

Bausch Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bausch Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bausch Health's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Shiller PE Ratio falls into.


;
;

Bausch Health Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bausch Health's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Bausch Health's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-3.273/128.7859*128.7859
=-3.273

Current CPI (Mar. 2025) = 128.7859.

Bausch Health Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 -2.354 100.500 -3.017
201509 2.366 100.421 3.034
201512 -16.851 99.947 -21.713
201603 -18.591 101.054 -23.693
201606 -16.274 102.002 -20.547
201609 -67.481 101.765 -85.399
201612 -30.307 101.449 -38.474
201703 33.704 102.634 42.292
201706 -1.988 103.029 -2.485
201709 66.966 103.345 83.452
201712 28.477 103.345 35.487
201803 -133.714 105.004 -163.998
201806 -48.927 105.557 -59.694
201809 -18.705 105.636 -22.804
201812 -19.306 105.399 -23.590
201903 -2.910 106.979 -3.503
201906 -9.412 107.690 -11.256
201909 -2.764 107.611 -3.308
201912 -81.088 107.769 -96.901
202003 -10.083 107.927 -12.032
202006 -21.236 108.401 -25.229
202009 4.418 108.164 5.260
202012 -8.554 108.559 -10.148
202103 -34.954 110.298 -40.813
202106 -33.044 111.720 -38.092
202109 10.692 112.905 12.196
202112 3.898 113.774 4.412
202203 -3.783 117.646 -4.141
202206 -8.047 120.806 -8.579
202209 22.126 120.648 23.618
202212 -22.030 120.964 -23.455
202303 -9.914 122.702 -10.406
202306 1.200 124.203 1.244
202309 -17.941 125.230 -18.450
202312 -1.867 125.072 -1.922
202403 -2.821 126.258 -2.877
202406 0.550 127.522 0.555
202409 -4.529 127.285 -4.582
202412 5.214 127.364 5.272
202503 -3.273 128.786 -3.273

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (MEX:BHC) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Bausch Health Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Bausch Health's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.